Tazemetostat

Tazemetostat
Trade Name
Orphan Indication Malignant pleural mesothelioma
USA Market Approval USA
USA Designation Date 2017-09-28 00:00:00
Sponsor Epizyme Inc.;400 Technology Square, 4th Floor;Cambridge, Massachusetts, 02139